Ajanta Pharma

{
  "main_header": {
    "sid": 178818,
    "name": "Ajanta Pharma",
    "stock_name": "Ajanta Pharma",
    "full_name": "Ajanta Pharma Ltd.",
    "name_url": "stocks-analysis/ajanta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "3,227.00",
    "chg": 38.25,
    "chgp": "1.2%",
    "dir": 1,
    "prev_price": "3,188.75",
    "mcapval": "40,316.73 Cr",
    "mcap": "Small Cap",
    "scripcode": 532331,
    "symbol": "AJANTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE031B01049",
    "curr_date": "Jun 23, 12:31 PM",
    "curr_time": "12:32 PM",
    "last_traded_at": "Jun 23, 12:31 PM IST",
    "bse_nse_vol": "1.17 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 23, 2026",
    "traded_date_str": "2026 06 23",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Ajanta Pharma Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-hold-4065023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AjantaPharmaLtd_mojoScore_4065023.png",
        "date": "2026-06-20 10:10:42",
        "description": "Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Ajanta Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-4043136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AjantaPharmaLtd_technicaldot_4043136.png",
        "date": "2026-06-10 08:00:32",
        "description": "Ajanta Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a series of positive signals from key technical indicators, reflecting improving price momentum and investor sentiment despite mixed signals from some longer-term trend measures."
      },
      {
        "title": "Ajanta Pharma Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-hold-4040946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AjantaPharmaLtd_mojoScore_4040946.png",
        "date": "2026-06-09 10:10:21",
        "description": "Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Ajanta Pharma Ltd. Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-technical-momentum-shifts-amid-mixed-signals-4024952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AjantaPharmaLtd_technicaldot_4024952.png",
        "date": "2026-06-01 08:00:33",
        "description": "Ajanta Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent 3.78% decline in its share price to ₹2,910.20, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, placing them in the context of the company’s recent price action and broader market performance."
      },
      {
        "title": "Ajanta Pharma Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-hold-by-marketsmojo-4019833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AjantaPharmaLtd_mojoScore_4019833.png",
        "date": "2026-05-29 10:11:03",
        "description": "Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 Mar 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 29 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ajanta Pharma Ltd. to 52-Week High of Rs 3314.8",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs33148-3999160",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AjantaPharmaLtd_priceRelatedfactors_3999160.png",
        "date": "2026-05-19 13:35:06",
        "description": "Surging past its previous peak, Ajanta Pharma Ltd. touched a fresh 52-week high of Rs 3314.8 on 19 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market."
      },
      {
        "title": "Ajanta Pharma Ltd. is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-ltd-is-rated-hold-3996651",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AjantaPharmaLtd_mojoScore_3996651.png",
        "date": "2026-05-18 10:10:43",
        "description": "Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 Mar 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Ajanta Pharma Gains 4.70%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-gains-470-4-key-factors-driving-the-weeks-momentum-3995593",
        "imagepath": "",
        "date": "2026-05-17 14:01:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>11 May:</strong> Stock opens at Rs.3,064.95, up 1.08% despite Sensex decline</p>\n                    <p><strong>13 May:</strong> Ajanta Pharma hits new 52-week high at Rs.3,161.1 and technical momentum shifts bullish</p>\n                    <p><strong>14 May:</strong> New 52-week high of Rs.3,182.3 amid sustained buying interest</p>\n                    <p><strong>15 May:</strong> Stock peaks at Rs.3,300 before closing at Rs.3,174.70, marking a slight pullback</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3,032.20</div></div>\n                    <div cl..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Ajanta Pharma Ltd. to 52-Week High of Rs 3300",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-ltd-hits-new-52-week-high-at-rs3300-3992260",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AjantaPharmaLtd_priceRelatedfactors_3992260.png",
        "date": "2026-05-15 09:37:43",
        "description": "Ajanta Pharma Ltd. has surged to a fresh 52-week high of Rs 3300 on 15 May 2026, marking a significant milestone in its price momentum. This advance comes after a sustained rally that has outpaced the broader market, with the stock delivering a 24.05% return over the past year compared to the Sensex’s decline of 8.37% during the same period."
      }
    ],
    "total": 656,
    "sid": "178818",
    "stock_news_url": "https://www.marketsmojo.com/news/ajanta-pharma-178818"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "19-Jun-2026",
      "details": "Pls find enclosed newspaper publication of AGM Notice",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "19-Jun-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on June 19 2026 for Ravi Agrawal trustee Ravi Agrawal Trust",
      "source": "BSE"
    },
    {
      "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
      "datetime": "18-Jun-2026",
      "details": "Pls find enclosed BRSR for FY 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has declared <strong>1400%</strong> dividend, ex-date: 10 Nov 25",
          "dt": "2025-11-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15",
          "dt": "2015-03-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22",
          "dt": "2022-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ajanta Pharma Ltd. is Rated Hold

2026-06-20 10:10:42

Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Ajanta Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility

2026-06-10 08:00:32

Ajanta Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by a series of positive signals from key technical indicators, reflecting improving price momentum and investor sentiment despite mixed signals from some longer-term trend measures.

Read full news article

Ajanta Pharma Ltd. is Rated Hold

2026-06-09 10:10:21

Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Ajanta Pharma Ltd. Technical Momentum Shifts Amid Mixed Signals

2026-06-01 08:00:33

Ajanta Pharma Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent 3.78% decline in its share price to ₹2,910.20, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these technical parameters in detail, placing them in the context of the company’s recent price action and broader market performance.

Read full news article

Ajanta Pharma Ltd. is Rated Hold by MarketsMOJO

2026-05-29 10:11:03

Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 Mar 2026. While the rating was revised on that date, the analysis and financial metrics presented here reflect the stock's current position as of 29 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Broad-Based Technical Strength Lifts Ajanta Pharma Ltd. to 52-Week High of Rs 3314.8

2026-05-19 13:35:06

Surging past its previous peak, Ajanta Pharma Ltd. touched a fresh 52-week high of Rs 3314.8 on 19 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to its sector and the broader market.

Read full news article

Ajanta Pharma Ltd. is Rated Hold

2026-05-18 10:10:43

Ajanta Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 Mar 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 18 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Ajanta Pharma Gains 4.70%: 4 Key Factors Driving the Week’s Momentum

2026-05-17 14:01:06

Key Events This Week

11 May: Stock opens at Rs.3,064.95, up 1.08% despite Sensex decline

13 May: Ajanta Pharma hits new 52-week high at Rs.3,161.1 and technical momentum shifts bullish

14 May: New 52-week high of Rs.3,182.3 amid sustained buying interest

15 May: Stock peaks at Rs.3,300 before closing at Rs.3,174.70, marking a slight pullback

Week Open

Rs.3,032.20

Read full news article

Broad-Based Technical Strength Lifts Ajanta Pharma Ltd. to 52-Week High of Rs 3300

2026-05-15 09:37:43

Ajanta Pharma Ltd. has surged to a fresh 52-week high of Rs 3300 on 15 May 2026, marking a significant milestone in its price momentum. This advance comes after a sustained rally that has outpaced the broader market, with the stock delivering a 24.05% return over the past year compared to the Sensex’s decline of 8.37% during the same period.

Read full news article

View All News